...
首页> 外文期刊>The Canadian Journal of Neurological Sciences: le Journal Canadien des Sciences Neurologiques >Telestroke: the management of acute ischemic stroke from a distance.
【24h】

Telestroke: the management of acute ischemic stroke from a distance.

机译:远程中风:从远处管理急性缺血性中风。

获取原文
获取原文并翻译 | 示例
           

摘要

The 1995 NINDS tissue plasminogen activator (tPA) trial ushered in a new era in the management of acute ischemic stroke. Tissue plasminogen activator proved to be the first effective treatment, one that challenged our approach to acute stroke management. This thrombolytic agent has a remarkably short therapeutic window of 4.5 hours and the sooner treatment is initiated the better the outcome. Furthermore, tPA carries a significant risk of secondary intracerebral hemorrhage. The appropriate admin-istration of tPA necessitates the availability of both rapid brain imaging and stroke expertise, resources that tend to be limited to Canada's large urban hospitals. Patients that do not reside within close proximity to urban centres have not been able to access this treatment. The advent of "Telestroke", a term coined by Levine and Gorman, increased the radius of access to tPA by linking patients in peripheral communities to neurologists and other stroke experts.
机译:1995年NINDS组织纤溶酶原激活剂(tPA)试验开创了急性缺血性中风的治疗新纪元。组织纤溶酶原激活剂被证明是第一种有效的治疗方法,它挑战了我们急性卒中治疗的方法。这种血栓溶解剂的治疗窗口非常短,为4.5小时,开始治疗越早结果越好。此外,tPA具有继发性脑内出血的重大风险。适当地管理tPA既需要快速的脑部影像学检查,也需要中风专业知识,而这些资源通常仅限于加拿大的大型城市医院。不在城市中心附近居住的患者无法获得这种治疗。 Levine和Gorman创造的“ Telestroke”一词的出现,通过将周围社区的患者与神经科医生和其他中风专家联系起来,增加了tPA的获取范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号